REQUEST A DEMO
Total
USD $0.00
Search more companies

Bonraybio Co., Ltd. (Taiwan, China)

Main Activities: Medical Equipment and Supplies Manufacturing
Full name: Bonraybio Co., Ltd. Profile Updated: February 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Chinese Download a sample report

Bonraybio Co., Ltd. is engaged in the development of high-precision and user-friendly medical instrument and solution. The company's main products include sperm routine testing, sperm advanced DNA fragmentation testing, and semen washing devices. The company was established in 2016 and is headquartered in Taichung City, Taiwan.

Headquarters
4F., No. 118, Gongye 9Th Rd, Dali Dist
Taichung City; Taichung City;

Contact Details: Purchase the Bonraybio Co., Ltd. report to view the information.

Website: http://www.bonraybio.com

Basic Information
Total Employees:
Purchase the Bonraybio Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Bonraybio Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Bonraybio Co., Ltd. report to view the information.
Incorporation Date:
January 12, 2016
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Vice President
Ownership Details
Purchase this report to view the information.
17.47%
Purchase this report to view the information.
14.18%
Purchase this report to view the information.
5.18%
Purchase this report to view the information.
5.02%
Purchase this report to view the information.
0.62%
Subsidiaries
Bonraybio Holding (Samoa) Co.,Ltd. (Samoa)
100%
Bonraybio Usa Corp. (United States)
100%
Company Performance
Financial values in the chart are available after Bonraybio Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
48.45%
Total operating revenue
48.45%
Operating profit (EBIT)
N/A
EBITDA
674.66%
Net Profit (Loss) for the Period
N/A
Total assets
12.36%
Total equity
9.79%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
-0.11%
Cash Ratio
1.42%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?